Physiomics secures new modelling contract with Numab Therapeutics
Physiomics (AIM: PYC) has been awarded a new contract by its long-standing client, Numab Therapeutics, to develop a mechanistic pharmacokinetic-pharmacodynamic…
0,006€
20,00%
Echtzeit-Aktienkurs PHYSIOMICS PLC LS -,004
Bid:
Ask:
Nachrichten zur PHYSIOMICS PLC LS -,004 Aktie
Physiomics shares boosted by latest contract
Physiomics Plc (LON:PYC) shares traded positively on Monday, after announcing it had been awarded a follow-on contract by an existing UK-based…
Physiomics shares jump 11% on contract news and senior hire
Shares in Physiomics rose 11% in early trading on Monday after the company announced its first biometrics contracts and a…